These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24124530)

  • 21. Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog.
    Zhang Q; Balourdas DI; Baron B; Senitzki A; Haran TE; Wiman KG; Soussi T; Joerger AC
    Cell Death Dis; 2022 Mar; 13(3):214. PubMed ID: 35256607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox state of p63 and p73 core domains regulates sequence-specific DNA binding.
    Tichý V; Navrátilová L; Adámik M; Fojta M; Brázdová M
    Biochem Biophys Res Commun; 2013 Apr; 433(4):445-9. PubMed ID: 23501101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
    Ethayathulla AS; Nguyen HT; Viadiu H
    J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally-occurring model for human cancer.
    Kelley ML; Winge P; Heaney JD; Stephens RE; Farell JH; Van Beneden RJ; Reinisch CL; Lesser MP; Walker CW
    Oncogene; 2001 Feb; 20(6):748-58. PubMed ID: 11314008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
    Fadda E; Nixon MG
    Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and function in the p53 family.
    Arrowsmith CH
    Cell Death Differ; 1999 Dec; 6(12):1169-73. PubMed ID: 10637432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 Family members p63 and p73 are SAM domain-containing proteins.
    Thanos CD; Bowie JU
    Protein Sci; 1999 Aug; 8(8):1708-10. PubMed ID: 10452616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 protein variants: structural and functional similarities with p63 and p73 isoforms.
    Courtois S; Caron de Fromentel C; Hainaut P
    Oncogene; 2004 Jan; 23(3):631-8. PubMed ID: 14737098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p63: the phantom of the tumor suppressor.
    Finlan LE; Hupp TR
    Cell Cycle; 2007 May; 6(9):1062-71. PubMed ID: 17426453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax.
    Patel S; George R; Autore F; Fraternali F; Ladbury JE; Nikolova PV
    Nucleic Acids Res; 2008 Sep; 36(16):5139-51. PubMed ID: 18676979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fold recognition of CP2 transcription factors gives new insights into the function and evolution of tumor suppressor protein p53.
    Kokoszynska K; Ostrowski J; Rychlewski L; Wyrwicz LS
    Cell Cycle; 2008 Sep; 7(18):2907-15. PubMed ID: 18787404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational stability and activity of p73 require a second helix in the tetramerization domain.
    Coutandin D; Löhr F; Niesen FH; Ikeya T; Weber TA; Schäfer B; Zielonka EM; Bullock AN; Yang A; Güntert P; Knapp S; McKeon F; Ou HD; Dötsch V
    Cell Death Differ; 2009 Dec; 16(12):1582-9. PubMed ID: 19763140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
    Lubin DJ; Butler JS; Loh SN
    J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Backbone resonance assignments of the human p73 DNA binding domain.
    Cino EA; Soares IN; Freitas MS; Silva JL
    Biomol NMR Assign; 2016 Apr; 10(1):49-51. PubMed ID: 26294377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
    Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
    Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservation of DNA-binding specificity and oligomerisation properties within the p53 family.
    Brandt T; Petrovich M; Joerger AC; Veprintsev DB
    BMC Genomics; 2009 Dec; 10():628. PubMed ID: 20030809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors.
    Kojima T; Ikawa Y; Katoh I
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1170-5. PubMed ID: 11243857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of tetramerization in p53 function.
    Chène P
    Oncogene; 2001 May; 20(21):2611-7. PubMed ID: 11420672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.